US Pharmaceutical Contract Manufacturing Market Size, Share, Impressive Industry Growth, Report 2027
The US pharmaceutical contract
manufacturing is anticipated to grow at a considerable of 4.8% CAGR during the
forecast period (2021-2027). The rising investments in R&D is one of the
prime factors affecting and driving the market. In the US the spending in
R&D is more in pharmaceutical and biotechnology market. The outsourcing of
services by companies dealing in pharma sector in the US has increased in order
to improve their margins related to profits. For this purpose, the companies
are investing more in R&D due to increasing technological complexity with
regards to development of drugs along with inject-able and sterile liquid dose
to form.
A full report of US Pharmaceutical Contract
Manufacturing Market is available at: https://www.omrglobal.com/industry-reports/us-pharmaceutical-contract-manufacturing-market
To gain on the opportunity key players
operating in the US pharmaceutical contract manufacturing had been adopting
strategy such as new launches in the country.
For instance, in November 2020, Catalent, Inc. which is one of the
providers of advanced delivery technology along with manufacturing solutions
for consumer health products and various therapies have notified the
acquisition of bone therapeutics cell therapy manufacturing subsidiary named as
Skeletal Cell Therapy Support SA (SCTS). This will enable the company to expand
its capabilities related to cell therapy.
To
learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-pharmaceutical-contract-manufacturing-market
Market
Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By
Category
o By
Product
o By
Services
·
Competitive Landscape- AbbVie Inc., Cardinal
Health., Catalent, Inc., Pfizer Inc., and Thermo Fisher Scientific Inc.
Key
questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the
market?
• How COVID-19 impacted the market?
o Deviation
from the pre-COVID-19 forecast
o Most
affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
US
Pharmaceutical Contract Manufacturing - Segmentation
By
Category
• Human Based Drugs
• Animals Based Drugs
By
Product
• Over-The-Counter (OTC) Drugs
• Active Pharmaceutical Ingredients (API)
• Finished Dosage Formulation
• Other
By
Services
• Manufacturing Services
• Non-Clinical Services
• Research and Development
For more customized data, request for report
customization @ https://www.omrglobal.com/report-customization/us-pharmaceutical-contract-manufacturing-market
Company Profiles
·
AbbVie Inc.
·
Ajinomoto
Bio-Pharma
·
Catalent, Inc
·
Cardinal Health.
·
Denison
Pharmaceuticals
·
Dravon Medical Inc.
·
East West
Manufacturing
·
HISUN USA, inc.
·
HTI Plastics
·
Hikma
Pharmaceuticals PLC
·
Lonza Capsules
& Health Ingredients
·
McGuff
Pharmaceuticals, Inc.
·
Medix Biochemica
·
NEEDLETECH, Corp.
·
Nextphase Medical
Devices, LLC.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Contact
Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no:
+91 780-304-0404
Company
Name: Orion Market Research
0 Comments